Page results
-
The rapid access chest pain clinic provides a quick and early specialist cardiology assessment for patients who need urgent assessment.
-
The heart failure service provides comprehensive care for patients with heart failure.
-
UCLH is a specialist centre for the treatment of urological cancers.
-
The UCLH post-COVID service is the lead provider for North Central London (NCL) and works with borough based services to provide support and assessment for patients with ongoing symptoms (long covid) following COVID-19 infection.
-
Ms Nicola Lack has been a consultant obstetrician at UCLH since 2012 and has been the labour ward lead since 2019. She has a background in maternal medicine and works within the diabetes team.
-
At UCLH we use many different drugs to treat patients with cancer. Chemotherapy is the treatment of cancer with drugs designed to control or destroy the growth of the tumour.
-
The Central Venous Access Device team provides a nurse-led service to teenagers and adults who have been referred to UCLH for cancer treatment.
-
The Interventional Oncology Service (IOS) at University College London Hospital (UCLH) is committed to improving the experience and outcomes for patients with cancer through cutting edge image guided interventions.
-
The lymphoedema service at UCLH provides assessment, diagnosis, treatment and management of cancer-related lymphoedema.
-
UCLH provides a comprehensive service to diagnose, treat and support people with cancer. We are a specialist centre for many types of cancer and treat patients from both our local area and across the country.
File results
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment